GE Healthcare Focuses on Dose Management Strategy at RSNA 2013


December 10, 2013

ASiR–V, is the next iteration of GE Healthcare's iterative reconstruction CT technology, which already has 3,600 installations worldwide and has provided more than 31 million patient scans to date. ASiR-V combines the speed of ASiR with the capabilities of Veo full model-based iterative reconstruction. Designed to significantly reduce dose relative to filtered back-projection (FBP) for both body and head modes, ASiR-V improves low contrast detectability, spatial resolution and image noise, and has the capability to reduce low signal artifacts such as streak artifacts when compared to FBP. ASiR-V is U.S. Food and Drug Administration (FDA) 510(k)-pending and not available for sale. For more information:

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.